CONSOLIDATED STATEMENTS OF STOCKHOLDER'S EQUITY - USD ($) $ in Thousands	Total	Cumulative effect of CECL adoption	Common Stock	Common Stock Common Class B	Additional Paid-In Capital	Accumulated Deficit	Accumulated Deficit Cumulative effect of CECL adoption	Accumulated Other Comprehensive Income
Balance a the beginning at Dec. 31, 2022	$ 31,514	$ (198)	$ 43,360	$ 3,388	$ 158,331	$ (173,784)	$ (198)	$ 219
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchases of Common Stock	(43)		(168)		125
Restricted stock grants issued	0		165	0	(165)
Restricted stock grants forfeited	(47)		(154)		107
Class B converted into Common Stock	0		25	(25)
Stock-based compensation expense	734				734
Net loss	(2,718)					(2,718)
Other comprehensive income	49							49
Balance at the end at Dec. 30, 2023	29,291		43,228	3,363	159,132	(176,700)		268
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock issued	0		113		(113)
Repurchases of Common Stock	(585)		(2,199)		1,614
Restricted stock grants issued	0		928	403	(1,331)
Restricted stock grants forfeited	0		(96)		96
Class B converted into Common Stock	0		18	(18)
Stock-based compensation expense	494				494
Net loss	(13,000)					(13,000)
Other comprehensive income	18							18
Balance at the end at Dec. 28, 2024	$ 16,218		$ 41,992	$ 3,748	$ 159,892	$ (189,700)		$ 286